3 Recruiting Prostate Cancer Clinical Trials in District Of Columbia
Explore active prostate cancer research studies enrolling across District Of Columbia. Verify eligibility and contact site coordinators.
📍 Find Near Me by DistanceBrowse by City
Recruiting Prostate Cancer Studies in District Of Columbia
🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
Study of TGF-β Receptor Inhibitor Galunisertib (LY2157299) and Enzalutamide in Metastatic Castration-resistant Prostate Cancer
📍 Sibley Memorial Hospital — Washington D.C., District of Columbia
View Study & Checklist ➔ 🟢 Recruiting Phase2 📋 Clinical Research Protocol
MRI-based Focal Intraprostatic Simultaneous Integrated Boost (SIB) Intensification With De-escalated Adaptive-risk SBRT for Patients With Low to Intermediate Risk Prostate Cancer
📍 Lombardi Comprehensive Cancer Center, Georgetown University — Washington D.C., District of Columbia
View Study & Checklist ➔ 🟢 Recruiting Observational / Diagnostic 📋 Clinical Research Protocol
Polygenic Risk Stratification Combined With mpMRI to Identify Clinically Relevant Prostate Cancer
📍 Howard University Hospital — Washington D.C., District of Columbia
View Study & Checklist ➔